Merck to Acquire Acceleron Pharma Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake damages buildings, disrupts power and air travel
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- CoreWeave stock drops on dilution fears and debt concerns
Merck (MRK) to Acquire Acceleron Pharma (XLRN) for $11.5 Billion, Deal Brings in Potential Blockbuster in PAH Says Analyst
September 30, 2021 7:56 AM EDTMerck (NYSE: MRK) announced today that it has agreed to acquire Acceleron Pharma (Nasdaq: XLRN) for $180 per share in cash in the deal valued at $11.5 billion.
Todays announcement has confirmed media reports that XLRN is in advanced talks with MRK over a takeover deal.
Strategic business development is a top... More



